This study is for women with specific types of breast cancer. It looks at whether reminders and counseling help them take their hormone medicine as prescribed. The study lasts up to 24 months and divides participants into four groups: Group 1 gets text message reminders about their medicine, Group 2 receives counseling calls, Group 3 gets both text reminders and counseling, and Group 4 continues usual care with educational information. Endocrine therapy (ET) is a treatment for hormone receptor positive breast cancer, meaning the cancer grows in response to hormones. The study aims to improve medication adherence, which means taking the medicine exactly as the doctor prescribes. Participants must have a smartphone or be willing to use one provided by the study, and they will use a special system to monitor their medication use.
- Study lasts up to 24 months, with various group assignments.
- Involves phone or text support to help take medicine regularly.
- Smartphones and monitoring tools provided if needed.